ROYAL LONDON ASSET MANAGEMENT LTD
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 863748
UNITED KINGDOM, X0
Position in VRTX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$119,851,014
+$7,237,199 QoQ
Shares Held
241,280
-4.3% QoQ
Ownership
0.095%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#96
of 1,735 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ROYAL LONDON ASSET MANAGEMENT LTD holds $597,315,774 across 9 Biotechnology names. VRTX ranks #3 (20.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
4,319,595 | $242,199,691 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,810,815 | $141,732,490 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
241,280 | $119,851,014 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
213,589 | $64,296,696 | |
| 5 | INCY |
Incyte Corp
|
190,323 | $21,575,015 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,887 | $2,423,699 | |
| 7 | INSM |
INSMED Inc
|
22,116 | $2,358,007 | |
| 8 | LEGN |
Legend Biotech Corp
|
75,000 | $2,166,000 |
All Filings in VRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $119,851,014 | 241,280 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $112,613,815 | 252,192 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $123,963,584 | 273,433 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $108,561,041 | 277,196 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $126,145,193 | 283,345 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $162,725,954 | 335,642 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $146,292,050 | 363,278 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $168,884,500 | 363,130 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $173,309,220 | 369,750 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $173,994,990 | 416,246 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $157,793,162 | 387,803 | Shares | Sole | 2024-03-01 | |
| 2023-09-30 | $135,795,251 | 390,508 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $109,622,428 | 311,507 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $80,428,864 | 255,273 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $26,243,460 | 90,877 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $25,039,998 | 86,482 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $25,480,297 | 90,423 | Shares | Sole | 2022-09-06 | |
| 2022-03-31 | $23,425,972 | 89,765 | Shares | Sole | 2022-09-06 | |
| 2021-12-31 | $19,058,425 | 86,787 | Shares | Sole | 2022-10-18 | |
| 2021-09-30 | $16,468,760 | 90,792 | Shares | Sole | 2022-10-18 | |
| 2021-06-30 | $19,015,120 | 94,307 | Shares | Sole | 2022-10-18 | |
| 2021-03-31 | $21,387,142 | 99,526 | Shares | Sole | 2022-10-17 | |
| 2020-12-31 | $22,777,740 | 96,377 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $26,951,581 | 99,043 | Shares | Sole | 2020-11-04 | |
| 2020-06-30 | $28,757,818 | 99,059 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $24,466,970 | 102,824 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||